Lutgens et al used serum citrulline concentration to monitor small bowel toxicity following myeloablative therapy given prior to hematopoietic stem cell transplant (HSCT). This is inexpensive and indicates recovery sooner than sugar permeability tests. The authors are from the Masstricht University and University Medical Centre St. Radboud in The Netherlands.
